Literature DB >> 9387759

[Clinical study on zhengan xifeng decoction in preventing and treating hypertensive nephropathy].

B K Zhang1, Z H Zhao.   

Abstract

Seventeen cases of hypertensive nephropathy with azotemia (test group) treated with Zhengan Xifeng Decoction (ZGXFI) and routine regimen of Western Medicine were observed. The result was compared with that of 15 cases treated with routine regimen alone (control group). After 3 months of treatment, the blood pressure, sodium excretion, blood urea nitrogen and creatinine were all reduced, while creatinine clearance rate (CCr) and residual renal function index (RRFI) were improved significantly in both groups. Compared with control group, the treatment on test group showed a more prominent effect on lowering of diastolic blood pressure, elevating the hemoglobin, reducing the blood level of triglyceride and creatinine as well as improving on CCr and RRFI, suggesting the deterioration of residual renal function could be restrained by ZGXFD, through improve the disorder of lipid metabolism, osmolality gradient and creatinine kinetics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9387759

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  1 in total

1.  Herbal medicine (Zhengan Xifeng Decoction) for essential hypertension protocol for a systematic review and meta-analysis.

Authors:  Yonglian Huang; Yanhong Chen; Hairong Cai; Dongjie Chen; Xiaoming He; Zhixiong Li; Xiaojing Cai; Xiaohong Peng; Yaxiu Huang; Shaoping Li; Qifeng Cao; Ping Wang; Bojun Chen
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.